Accutar is a clinical stage biotech company focused on AI-empowered drug discovery, and its application to the discovery and development of clinically differentiated medicines. Be transformative.

Shanghai Henlius Biotech, Inc. announced that its New Drug Application for HLX04-O, a recombinant anti-VEGF humanized monoclonal antibody injection for treating wet age-related macular ...